Online Only Articles

Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA
Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA
Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA
Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA
Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA
Vol. 103 No. 7 (2018): July, 2018 https://doi.org/10.3324/haematol.2017.186908